POLYTECH Health & Aesthetics Unveils Comprehensive Microthane® Portfolio for Enhanced Patient Outcomes

POLYTECH Health & Aesthetics Reveals Full Microthane® Portfolio

In a significant development for the field of breast surgery, POLYTECH Health & Aesthetics announced that its complete Microthane® portfolio is now available for surgeons and patients alike. The company, which has garnered global recognition over its 40 years of experience in silicone implants, is committed to advancing technologies that meet the evolving needs of aesthetic and reconstructive breast surgery. This latest offering was confirmed by its Notified Body and is poised to enhance surgical options across over 90 countries.

Understanding the Microthane® Technology

POLYTECH's Microthane® surface technology is designed to maximize patient comfort and surgical outcomes. The portfolio includes two gel options: the standard EasyFit™ Gel and the innovative B-Lite® gel. Each of these implants features a unique manufacturing process that results in a smooth posterior surface and a seamless edge transition, ensuring ease of use for surgeons.

The B-Lite® Microthane® implants blend the benefits of the established Microthane® surface with groundbreaking lightweight gel technology. With weights that can be reduced by up to 30% compared to traditional silicone implants of similar size, these implants help minimize stress on surrounding tissues. As scientific studies suggest, this reduced tissue stress is pivotal in achieving stable and predictable long-term outcomes for patients.

Advantages in Breast Reconstruction

The incorporation of Microthane® technology in breast reconstruction procedures yields remarkable results. Clinical findings indicate a lower rate of complications such as capsular contracture and reoperation in procedures utilizing Microthane® implants. The combination of both Microthane® surface and B-Lite® lightweight gel offers significant advantages in stability, thus ensuring that implants are not only comfortably integrated but also remain securely positioned within the breast.

That said, the innovation doesn’t stop there; POLYTECH demonstrates an unwavering commitment to continuous improvement.

A Commitment to Innovation

CEO Prof. Dr. Karsten Hemmrich expressed enthusiasm regarding the portfolio's availability, emphasizing how surgeons globally have trusted the combination of Microthane® and B-Lite® technologies. By providing both options, POLYTECH aims to sustain predictable, long-term outcomes across both aesthetic and reconstructive needs.

As a Germany-based medical technology leader, POLYTECH Health & Aesthetics manufactures all breast implants at its facility in Dieburg, demonstrating its dedication to quality and precision in every product. With such advancements, the company is setting a benchmark in the world of breast enhancement and reconstruction, steadily moving towards redefining the norms in surgical results.

POLYTECH continues to blend engineering excellence with scientific collaboration and innovation, ensuring that their offerings not only meet but exceed patient expectations. The full Microthane® portfolio stands as a testament to their long-standing commitment to patient-centric developments, ultimately aiding surgeons and their patients in their journey towards achieving their desired outcomes.